P
ZBH icon

&Partners’s Zimmer Biomet ZBH Stock Holding History

&Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Buy
21,527
+1,926
+10% +$177K 0.01% 921
2025
Q4 		$1.75M Sell
19,601
-5,657
-22% -$536K 0.01% 931
2025
Q3 		$2.48M Buy
25,258
+3,128
+14% +$310K 0.02% 672
2025
Q2 		$2.02M Buy
22,130
+7,592
+52% +$734K 0.02% 666
2025
Q1 		$1.63M Buy
14,538
+3,546
+32% +$379K 0.02% 621
2024
Q4 		$1.15M Buy
10,992
+6,161
+128% +$661K 0.01% 713
2024
Q3 		$521K Buy
4,831
+2,135
+79% +$233K 0.01% 852
2024
Q2 		$293K Buy
+2,696
New +$318K 0.01% 722

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

&Partners's ZBH Position: Q1 2026 in Review

&Partners increased its Zimmer Biomet (ZBH) stake by 9.8% in Q1 2026, buying an estimated $177K and bringing the position to 21,527 shares worth $1.95M. The position accounts for 0.01% of the portfolio, ranked #921.

&Partners first reported a position in ZBH in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.48M in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • &Partners held 21,527 shares of Zimmer Biomet worth $1.95M as of Q1 2026.
  • &Partners bought 1,926 Zimmer Biomet shares in Q1 2026, an estimated $177K.
  • Zimmer Biomet made up 0.01% of &Partners's portfolio in Q1 2026, its #921 holding.
  • &Partners first reported a position in Zimmer Biomet in Q2 2024 and has held it in 8 quarters since.
  • &Partners's Zimmer Biomet position peaked at $2.48M in Q3 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.